TSANZ home

Results for "lung function testing"

Home 5 Search query for: lung function testing
Results for "lung function testing"
VOLUME 5.04 – JUNE 2020

VOLUME 5.04 – JUNE 2020

Research Roundup:

June 2020

 

Welcome Message

Welcome to this exciting update of the Research Roundup.

Many of you would have experienced the success of our first virtual Ann Woolcock Award presentation session. I congratulate all the finalists for adapting so well to this new format and to the audience who quickly settled into the Zoom Q&A system and challenged the speakers with stimulating questions.

The RSC members are having a well-earned break from their arduous but rewarding grant review duties, and both I and the Society sincerely thank these members for all their hard work. Their break will be short as awards will open again in the coming months.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the June edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

2020 Respiratory Research Excellence Awards

 

TSANZ congratulates the following award winners!!!

 

Ann Woolcock New Investigator Award Winner: Kurtis Budden

Ann Woolcock New Investigator Award Finalists: Kak-Ming Ling, Rebecca Stockwell, Steven Taylor, Pamela Laird, Razia Zakarya

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship: Simon Craig

TSANZ/AstraZeneca Respiratory Research Mid-Career Fellowship: Hayley Scott

TSANZ/AstraZeneca Respiratory Research Early Career Fellowship: Steven Taylor

Australian Cystic Fibrosis Research Trust 2020 Innovation Grant: Abdullah Tarique, Peter Sly, Emmanuelle Fantino, Clair Wainwright, and Scott Bell

Vertex Adult Cystic Fibrosis Research Award: Sandra Hodge, Peter Zalewski, David Parsons, Andrew Tai, Sally Chapman, Judith Morton, and Emily Hopkins

Vertex Paediatric Cystic Fibrosis Research Award: Shafagh Waters and Adam Jaffe

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease: Mariane T Turner, Samuel Sameh, Robert A Cohen, and Deborah H Yates           

TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health: Kristin Carson-Chahhoud

TSANZ Peter Phelan Paediatric Research Award: Shivanthan Shanthikumar

TSANZ / Boehringer Ingelheim Australia COPD Travel Award: Katrina Tonga

TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award: Hajar Ali

TSANZ/JRS Early Career Development Award: Saleela Ruwanpura

Janet Elder International Mid-Career Travel Award: David G Chapman

Janet Elder International Early Career Travel Award Recipient 1: Steven Taylor

Janet Elder International Early Career Travel Award Recipient 2: Tony Zhang

TSANZ Respiratory Nurses Career Development Award for Indigenous Research:Kobi Schutz

 

TSANZ would like to thank our partners and sponsors for their support of excellent respiratory research and researchers!

2020 TSANZ Awards by Nomination

At TSANZ 2020 AGM we recognised seven leaders in their field of lung health.

TSANZ 50th Anniversary Medal for Education and Training – Associate Professor David Fielding.

The 50th Anniversary Medal is awarded each year in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand.

TSANZ Research Medal – Professor Shyamali Dharmage, Professor Alan James

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand. This year, due to the calibre of nominations, the TSANZ Board has chosen two recipients for the TSANZ Research Medal.

TSANZ Society Medal – Associate Professor Tara Mackenzie

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand.

Fellowships

  • Professor Richard Beasley
  • Professor Margaret Wilsher
  • Professor Ross Vlahos

Each year the TSANZ board considers peer nominations for Fellow status of the Thoracic Society of Australia and New Zealand (TSANZ). Fellow status is awarded to members who have demonstrated exceptional contributions to the field of respiratory health in Australia or New Zealand.

Congratulations to all!

Respirology – Editor’s Choice 

Respirology Issue 25.5 May 2020

 

Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis

Na Wu, Changjiang Xue, Shiwen Yu and Qiao Ye

 

Chest HRCT of 2 peatients with natural stone-associated findings (top) and 2 patients with artificial stone-associated silicosis (Bottom)

DOI: 10.1111/resp.13744

 

Acute exacerbations of fibrotic interstitial lung diseases

Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Jun Fukihara, Masahiko Ando, Tomonori Tanaka, Naozumi Hashimoto, Koji Sakamoto and Yoshinori Hasegawa

 

Researchers from the ILD collaborative team from Japan and US. From left to right: (front) Dr. Yasuhiro Kondoh, Dr. Kevin K. Brown, Dr. Yoshinori Hasegawa; (back) Dr. Atsushi Suzuki, Dr. Koji Sakamoto, Dr. Naozumi Hashimoto, Dr. Kensuke Kataoka, Dr. Yuji Saito.

DOI: 10.1111/resp.13682

Respirology Issue 25.6 June 2020

 

Effects of E-cigarette E-liquid components on bronchial epithelial cells: Demonstration of dysfunctional efferocytosis

Miranda P. Ween, Rhys Hamon, Matthew G, Macowan, Leigh Thredgold, Paul R. Reynolds and Sandra J. Hodge

 

A collection of e-cigarettes and e-liquids for sale to vapers

DOI: 10.1111/resp.13696

 

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF

Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J. Butte and Harold R. Collard

 

 

The research team from the University of California San Francisco in the United States (c269928 represents Brett Ley)

DOI: 10.1111/resp.13753

TSANZSRS 2020 Abstracts

Due to the COVID-19 pandemic, the TSANZSRS 2020 ASM has been postponed until 30 April – 4 May 2021. This supplement contains Abstracts that were accepted for presentation at the 2020 meeting.

Volume 25, Issue S1 TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, 27–31 March 202

 

Invitations and surveys

 

CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

Dear Members of the Thoracic Society of Australia and New Zealand,

Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

https://www.surveymonkey.com/r/F38Q8K2

We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

 

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

Dear Colleagues,

We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

Caring for People with Intellectual Disability survey

Thank you for considering our invitation
A/Prof Nathan Wilson, Western Sydney University
Dr Peter Lewis, Western Sydney University
Ms Virginia Howie, Central Queensland University
Dr Melissa Desroches, University of Massachusetts, Dartmouth

Kind regards,
Virginia

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

 

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland
Professor of Physiotherapy, Monash University and Alfred Health
Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

.

 

VOLUME 5.04 – JUNE 2020

VOLUME 3.03 JUNE 2018

Research Roundup:

June 2018

.
 

Welcome Message

We are deep in conference season with both the TSANZSRS18 and the ATS Congress now finished for another year. At TSANZSRS18, respiratory research received a much needed boost of over $2 million funding from TSANZ, LFA, CFA, NAC, and our partners. These awards were announced at the Respiratory Research Excellence Awards session and we hope you enjoyed this new -look celebration. You can recap the TSANZ research winners on our website. ATS Congress was another huge event and we invite you to look at the limbic stories below for highlights. The next international meeting in the respiratory circuit is the ERS Congress in Paris Sept 15-19. There are ERS travel awards available still so please look into these if you are planning on attending. 

We would also like to highlight the funding opportunities available for those researching alpha-one antitrypsin deficiency in lung disease. There are large grants on offer from the Alpha One Association and these do not require any specific membership and international collaborations for eligibility.

Furthermore, the Thoracic Society Research Medal and other awards by nominations are now open. Please consider nominating a member in recognition of their outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand.

Finally, I encourage you all to complete the survey at the end of this newsletter in regards to The Global Lung Function Initiative (GLI). The GLI has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations. They are now seeking feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation.

Enjoy the June edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

TSANZ NZ Branch ASM Travel Grant – closing 14 Jul 18

Vertex Cystic Fibrosis Research Awards – NACFC closing 08 Aug 18

Lung Foundation Australia / A Menarini Pty Ltd 2018 Travel Awards – ERS closing 29 Jun 18, APSR closing 09 Jul 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Support TSANZ

This year, TSANZ is asking members to provide a tax deductible donation to support our work in respiratory research and/or clinical care. You can choose to donate to one, or both, of the programs detailed below:

1. TSANZ 50th Anniversary Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor. In 2018, this program supported the development of two clinical programs:

  • Take the Bronchiectasis Toolbox on the road: A program aiming to build upon the tremendous work of the Bronchiectasis Toolbox by increasing its effectiveness in in Australia’s regional and remote areas. TBTR is designed to bridge the gap between electronic platform and clinician by supplementing the Toolbox’s online content with face-to-face educational workshops, as well as further online resources and telephone and email support.
  • A clinician’s guide to early diagnosis of PCD – when common symptoms mean so much more!: An online educational resource for medical staff to aid in the early and accurate diagnosis of Primary Ciliary Dyskinesia (PCD). This resource aims to increase medical awareness of suggestive symptoms as well as referral directions for diagnostic testing. This guide will not only better enable clinicians to identify PCD in its crucial early stages, but provide them with the knowledge of specific PCD therapy aims that they need to ensure their patients receive the best treatment possible.

 – CLICK HERE to make a donation.

2. Joint TSANZ/LFA Research Program

In 2018 were able to recognise three respiratory health researchers for their work in combating serious lung disease. The 2018 Lungs for Life Research Award winners were:

Professor Phil Hansbro: Cell free microRNA: potential biomarkers for the early detection of lung cancer

Dr Malcolm Starkey: Understanding how group 2 innate lymphoid cells in early-life regulate postnatal lung development and susceptibility to chronic lung diseases

Dr Megan Jensen: Maternal and Early Life Vitamin D exposure and asthma risk in high risk infants

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease. Please CLICK HERE to make a donation.

3. Leave TSANZ a gift in your will – If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy. If interested, please notify us by ticking the box on the Support TSANZ form attached. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

4. TSANZ New Zealand Branch IncorporatedCLICK HERE to make a donation.

New Zealand members are able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.

TSANZ Medals  

We apologise for the mistake we made in our latest article on the Society Medal in the May e-news. In response, we would like to congratulate the recipients of three prestigious TSANZ Medals: the Society Medal, the Research Medal, and the 50th Anniversary Medal. These awards are presented to TSANZ members as an acknowledgement of their outstanding contributions to respiratory health in research, education, and the health sector.

Nominations for the year have now opened! If you wish to nominate an extraordinary TSANZ member for their work in respiratory health, please visit https://www.thoracic.org.au/researchawards/tsanz-awards-by-nomination for more information.

Previous recipients of these prestigious TSANZ Medals are listed below:

The Research Medal

1992 Professor Ludwig Engel (posthumously) 
1994 Professor Colin Sullivan
1996
Professor Terry Nicholas
Professor Peter Phelan
1998 Professor Judith Black
1999 A/Professor Philip Thompson
2000 Professor Richard Beasley
2003 A/Professor Peter Gibson
2005 Professor Peter Sly
2006 A/Professor Gary Anderson
2007 Professor Haydn Walters
2008 Professor Bruce Robinson
2009 Professor Peter Bye
2010
Professor Guy Marks
2011
Professor Bill Musk
Professor Michael Abramson
2012 A/Professor Paul Forrest
2013 Professor Anne Chang
2014 Professor Scott Bell
2015 Professor Richard Beasley
2016 Professor Ron Grunstein
2018 Professor Peter Le Souef

 

 

The Society Medal

1992 Dr Maurice Joseph
1993 Dr Roy Mills
1994 Professor Tom O’Donnell
1995 Dr Michael Pain
1996 Dr Alastair Campbell (posthumously)
1997 Dr Michael Burns
1998 Professor Ann Woolcock
1999 Dr Kevin Finucane
2002 Dr Peter Rothwell
2004 Dr Abraham Rubinfeld
2006 A/Professor Charles Mitchell
2008 Dr Bob Edwards
2011 Judge John O’Meally
2012 Professor Norbert Berend
2013 Professor Philip Thompson
2014 Professor Peter van Asperen
2015 Professor Martin Phillips
2016 Professor Iven Young
2017 Professor Peter Holmes
2018 Professor Paul Reynolds

 

50th Anniversary Medal

2011 Dr Paul Zimmerman 
2012
A/Professor Tara Mackenzie 
2013 Professor Fiona Lake
2014 A/Professor Chien-Li Holmes-Liew 
2015 Professor Hubertus Jersmann
Dr Nicholas Saltos
2016 Professor Peter Frith
2017 Professor Jennifer Alison
Professor Richard Ruffin

 

Respirology Issue – Editor’s Choice

Vitamin D and respiratory health in the Busselton Healthy Ageing Study

SIOBHAIN MULRENNAN, MATTHEW KNUIMAN, JOHN P. WALSH, JENNIE HUI, MICHAEL HUNTER, MARK DIVITINI, KUN ZHU, BRIAN R. COOKE, ARTHUR W. (BILL) MUSK and ALAN JAMES

DOI: 10.1111/resp.13239

 

A Busselton Health Study participant undergoing lung function testing

 

Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema

JOSEPH JACOB, BRIAN J. BARTHOLMAI, SRINIVASAN RAJAGOPALAN, RONALD KARWOSKI, ARJUN NAIR, SIMON L.F. WALSH, JOSEPH BARNETT, GARY CROSS, EOIN P. JUDGE, MARIA KOKOSI, ELISABETTA RENZONI, TOBY M. MAHER and ATHOL U. WELLS

DOI: 10.1111/resp.13231

 

The Royal Brompton Hospital in South Kensington, London, UK (left), and the Mayo Clinic in Rochester,  MN, USA  (right).

 

Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy

JUNYA OKUMURA, YUICHIRO SHINDO, KUNIHIKO TAKAHASHI, MASAHIRO SANO, YASUTERU SUGINO, TETSUYA YAGI, HIROYUKI TANIGUCHI, HIDEO SAKA, SHIGEYUKI MATSUI, YOSHINORI HASEGAWA on behalf of the Central Japan Lung Study Group

DOI: 10.1111/resp.13232

 

The Nagoya University Respiratory Tract Infection Team studied approximately 1500 patients with pneumonia from 10 different hospitals on behalf of the Central Japan Lung Study Group.

 

Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease 

LASZLO T. VASZAR, BRANDON T. LARSEN, KAREN L. SWANSON, JAY H. RYU AND HENRY D. TAZELAAR

DOI: 10.1111/resp.13223

 

The research team from the Mayo Clinics in Scottsdale, AR, and Rochester, MN, USA, from left to right: Karen L Swanson, Henry D Tazelaar, Laszlo T Vaszar, Brandon T Larsen and Jay H Ryu (inset top right).

 

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial

STEVEN MCKINSTRY, JANINE PILCHER, GEORGE BARDSLEY, JAMES BERRY, SUSANNE VAN DE HEI, IRENE BRAITHWAITE, JAMES FINGLETON, MARK WEATHERALL and RICHARD BEASLEY

DOI: 10.1111/resp.13185

 

Nasal High Flow therapy in action

 

Pharmacokinetics and safety of paclitaxel delivery into porcine airway walls by a new endobronchial drug delivery catheter

HISASHI TSUKADA, PLAMENA ENTCHEVA-DIMITROV, ARMIN ERNST, SAMAAN RAFEQ, JOHN H. KEATING, KIRK P. SEWARD and LONNY YARMUS

DOI: 10.1111/resp.13214

 

The Blowfish® Transbronchial Micro-Infusion Catheter

 

Research Project and Survey Requests

The Global Lung Function Initiative (GLI) Survey

The Global Lung Function Initiative (GLI) has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations.   

 As part of our broader work we are interested in receiving feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation. We would greatly appreciate you taking the time to complete the survey to help us understand the experiences of your own research group and/or clinical department.  

This short survey should take ~ 5 minutes to complete and will assist in further informing GLI activities and how we approach future implementation. Individuals and their institutions will not be identified. Outcomes of the survey will be made publicly available on the GLI website. 

We are currently working to develop reference equations for lung volumes and if you or your colleagues have lung volume data in healthy individuals please do visit www.lungfunction.org for more information on this latest GLI initiative.  

Survey sent on behalf of the Global Lung Function Initiative Network: 

https://www.surveymonkey.com/r/DB9LYDJ?PleaseSpecify=[PleaseSpecify_value]

Explaining chronic breathlessness

Chronic breathlessness has been defined as ‘breathlessness that persists despite optimal treatment of underlying pathology and results in disability’ (Johnson et al. Eur Respir J 2017;49 (5)). This symptom is a common daily experience for people with a range of malignant and non-malignant respiratory, cardiovascular and neuromuscular conditions.

We know very little about how health professionals explain chronic breathlessness to people living with this symptom. This survey seek to collect information on the  explanations health professionals, from a variety of professional disciplines, use when explaining chronic breathlessness  to people living with this symptom (and their views on whether there is specific information which should  and should not be included in explanations). 

This electronic survey contains 13 questions and should take not more than 10 -12 minutes to complete. All responses will be confidential and anonymised by allocating an ID code to each participant. Details concerning the process including data management and privacy consideration are included in the Participant Information sheet included within the opening screens of the survey.

Ethical approval has been received from the Human Research Ethics Committee of the University of South Australia (ID: 200896)

For further information or to participate, please click here: 

Explain chronic breathlessness’   or copy and paste the following into your browser:

https://www.surveymonkey.com/r/Explain-Chronic-Breathlessness

For further information please contact Dr Marie Williams (E: marie.williams@unisa.edu.au or Ph: +61-8-8302 1153, University of South Australia) on behalf of the research team (Dr Kylie Johnston and Prof Dina Brooks)

 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 2.01 FEBRUARY 2017

Research Roundup:

February 2017

.
 

Welcome Message

Welcome to 2017 and our first Research Roundup of the new year.

As I emerge briefly from my grant writing, I would like to let everyone know that icare dust diseases care have opened their award round for 2017. They will offer Discovery grants, Translational research grants, and Clinical trial infrastructure support grants. Please see below for more details.

I’d also like to introduce a new feature to the Research Roundup, the Respirology Editor’s Choice. In it you will find links to open access articles from each monthly publication, accompanied with photos of the authors – many of which are TSANZ members.

Lastly, for those of you who have en bloc membership with ERS, the ERS Gold Medalgrants of €50,000 are now available. This award goes to researchers who have made an outstanding contribution in COPD, Asthma, or IPF, and are currently pursuing an active research project in these fields.

I wish you well in your grant writing and preparation for the ASM. 

Enjoy your February Research Roundup,

Prof Phil Hansbro

Chair, Research Sub-Committee

The following articles will take you to thelimbic.com

A watershed moment for COPD research. A genome-wide association study of almost 50,000 people has uncovered 68 high priority genes as targets for future COPD drug development. We find out more from co-author and respiratory physician Professor Alan James, from the University of Western Australia. Read more.

Respiratory infection an ‘under-appreciated’ MI risk. People have a 17-fold increased risk of acute MI within the first seven days of experiencing lower respiratory infection symptoms an Australian study shows. Read more.

+ Spirometry report highlights access issues. A new report into the use of spirometry in the diagnosis and management of chronic airways disease has highlighted “huge barriers” to access. Read More.

$1 million response to thunderstorm asthma. In response to the thunderstorm asthma event in Melbourne and Geelong last November, the Victorian Government has pledged $1 million to better understand and help predict the rare phenomenon. Read more.

Lung cancer remains #1 cause of cancer deaths. A report from the Australian Institute of Health and Welfare confirms that lung cancer remains Australia’s leading cause of cancer deaths – with over 9,000 deaths from the disease anticipated in 2017. Read more.

Open Awards

 

Watch this space for more award announcements…

Respirology Editor’s Choice

Respirology Issue 22.2

Infant lung function predicts asthma persistence and remission in young adults

By Owens et al. (resp.12901/ RES-16-007.R2)

 

Dr Louisa Owens with Infant Lung Function testing equipment

 

Characteristics, incidence and outcome of patients admitted to intensive care because of pulmonary embolism

By Winterton et al. (resp12881/RES-15-779.R2)

Incidence of pulmonary embolism over time relative to intensive care unit admissions (top) and relative to the overall Australia and New Zealand population (bottom).

 

Respirology Issue 22.1

Ecological study on solid fuel use and pneumonia in young children: A worldwide association

By Accinelli et al. (resp.12865/ RES-16-237.R1)

Illustrative example of indoor biomass pollution and the favourable impact of the installation of a non-polluting stove in Peru.

Malignant pleural fluid from mesothelioma has potent biological activities

By Lee et al. (resp12874/RES-16-044.R1)

From left to right: Prof Gary Lee, Dr Su Lyn Leong, Hui Min Cheah, Dr Sally Lansley and Prof Jenette Creaney at the Harry Perkins Instituteof Medical Research in Perth, Western Australia.

Lungs for Life Grant Bulletin

The Lungs for Life project has identified the following direct-to-researcher grants and awards due between late March and mid-2017:

Ramaciotti Foundation’s (Perpetual Trustees) Biomedical Research Award – closes 17/03/17
Presented every two years to a group or individual undertaking biomedical research within universities, public hospitals, medical research institutes or other similar organisations. The award funds projects including personnel, equipment, major infrastructure improvements or new laboratories that help an existing, well-funded program of research or enable a major new program to begin. Traditionally, it funds a need that would not attract funding elsewhere.

Channel 7 Children’s Research Foundation Grants – closes 21/03/17
Supports health, educational or social research to encourage and advance investigation into the cause, prevention, diagnosis and treatment of any condition that may affect the general health, education or welfare of children in South Australia and the Northern Territory.

World of Children Health Award (2017) – closes 01/04/17
The Health Award recognises an individual who has made a significant contribution to children in the fields of health, medicine or the sciences.

L’Oreal Australia and New Zealand for Women in Science Fellowships – 2017 – closes 03/04/17 
For early career women scientists to consolidate their careers and rise to leadership positions in science. The Fellowships are awarded to women who have shown scientific excellence in their career with an appropriate research plan that will be assisted by the one-year Fellowship.

Wellcome Trust Technology Transfer Translation Awards – closes 14/04/17
Translation Awards aim to bridge the funding gap in the commercialisation of new technologies in the biomedical area. Current highlight area is Restoring the Body; however projects covering any aspect of technology development from a range of disciplines – including physical, computational and life sciences – will be considered.

The Rebecca L. Cooper Medical Research Foundation Al and Val Rosenstrauss Medical Research Fellowship – closes 28/04/17
The Al and Val Rosenstrauss Research Fellowships are named in honour of the late Al Rosenstrauss OAM and his wife, Val, for their contribution to the work of the Foundation over a period of more than 28 years. Research project must be in one of the nominated areas of medical research that are supported by the Foundation; Brain Sciences, Diabetes, Geriatrics, Lung Disease (other than cancer), Rheumatology, and Vision Sciences. Applicants who have received previous funding, or worked in a laboratory supported by the Foundation, will be favoured.

Sylvia and Charles Viertel Charitable Foundation Clinical Investigatorships – closes 30/04/17
To stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment.

Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship – closes 30/04/17
Providing salary and project grant support for outstanding medical researchers.

Bill & Melinda Gates Foundation Grand Challenges Explorations Round 19 – closes 11/05/17
Early-stage innovative research projects from a range of disciplines and regions.

Winston Churchill Memorial Trust Fellowship – closes 15/05/17
To provide an opportunity for Australians to travel overseas (for 4 – 6 weeks) to conduct research in their chosen field that is not readily available in Australia.

The Prince Charles Hospital Foundation Experienced Researcher Project Grants – closes 20/05/17
To support strategic, world-class, sophisticated research on the Foundation’s campus or in significant partnership with this campus in the priority areas of: Heart disease – heart failure, valvular heart disease, congenital heart disease; Lung disease – lung cancer, asbestos related diseases, COPD, pulmonary hypertension, cystic fibrosis, sleep disorders, asthma; Dementia – Alzheimer’s disease, vascular dementia, Lewy Body disease, fronto-temporal dementia; Arthritis – osteoarthritis, joint replacement, growing cartilage.

Australian Institute of Policy and Science – CSL Florey Medal – closes 28/05/17
Award for an Australian biomedical researcher with significant achievements in biomedical science and/or human health advancement for research conducted primarily in Australia. Winners are expected to attend a presentation ceremony in Canberra in November.

The NVIDIA Foundation Compute the Cure Cancer Research Grants – closes 28/05/17
To advance the fight against cancer. Will fund projects that use computational omics to dramatically impact the battle against cancer and reduce the time it takes for research outcomes to be used effectively in a clinical environment.

Australian Institute of Policy and Science – CSL Young Florey Medal – closes 06/06/17
Award for an Australian biomedical researcher with significant early career achievements in biomedical science and/or human health advancement. Selection Criteria: Excellence in research achievement in the biomedical science and/or human health advancement; and Excellence and passion in communication and community engagement to promote understanding and engagement in science.

John T Reid Charitable Trusts – closes 28/06/17
The John T Reid Charitable Trusts is a national funding organisation with a wide ranging commitment to philanthropy around Australia. Funding focus is on community and social welfare, health support, aged and palliative care, education and youth support, arts and cultural heritage and the environment.

Lung Cancer Research Foundation Grants 2017 – closes 01/07/17
Lung cancer projects focused on one or more of the following: basic science; translational research; clinical research; supportive care; quality of care/outcomes.

 

Research Project and Survey Requests

Reminder: Survey invitation for Nurses and Allied Health on advance care planning in COPD

Dear Colleague

Our research team is conducting a survey to understand Palliative Care Nurses, Respiratory Nurses, and Allied Health Professionals that work in respiratory care’s knowledge and practice around advance care planning in patients with COPD. From the results of this study we hope to develop educational resources to assist health professionals when caring for this patient group.

We invite you to participate in a survey, that should take only 10-15 minutes to complete. Several disciplines are represented in the overall survey, however you will be directed to only those questions relevant to your discipline.

Ethics approval has been granted for this study from the University of Sydney. All responses will be anonymous and confidential. No personal information that could identify you is being collected and your email address will not be linked to your survey response. Your consent to participate in this study is implied by completing the survey.

Further information about this research study is provided in the enclosed document [DOWNLOAD]. If you have any questions regarding this research, please do not hesitate to contact Dr Rebecca Disler directly. Thank you in advance for participating.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser:   https://www.surveymonkey.com/r/ACPHealthProf

Kind regards

Dr Rebecca Disler | Senior Lecturer in Chronic Disease | The University of Sydney
Email: rebecca.disler@sydney.edu.au  | Tel: 0406 876 587

Dr Natasha Smallwood | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital
A/Prof Louis Irving | Respiratory Physician Department of Respiratory Medicine | The Royal Melbourne Hospital
Prof David Currow | Palliative Care Physician Flinders University | Adelaide

STUDENT DECLARATION
Yuxiu Cui will be analysing the anonymous study results as the basis for her degree of Bachelor of Advanced Nursing (Honours) at The University of Sydney. This will take place under the supervision of Dr Rebecca Disler.

 

Acceptability and Perceived Benefit of Prehabilitation amongst Thoracic surgeons throughout Australia

Dear TSANZ members

This survey is being conducted to determine the Acceptability and Perceived Benefit of Prehabilitation amongst Thoracic Surgeons throughout Australia. It is part of a larger research project looking at the benefits of prehabilitation for individuals having lung cancer surgery in Australia.

This survey is open to thoracic surgeons currently practicing in Australia and New Zealand.

Your help in completing this survey is greatly appreciated. It is hoped that the results of this survey will assist the direction of future research into exercise interventions for patients with lung cancer.

It is anticipated this survey will take approximately 10 – 15 minutes to complete. Responses to this survey are anonymous and will remain confidential. All responses are voluntary. Completion of the survey will indicate your consent to participate. Please follow the link below to complete the survey online.

https://www.surveymonkey.com/r/PREHAB

For further information or assistance with completing this survey please contact Anna Shukla (Senior Cardiorespiratory Physiotherapist – St Vincent’s Hospital, Melbourne):

Email: anna.shukla@svha.org.au

This research has been approved by the School Of Health Sciences Human Research Ethics Advisory group (Ethics I.D 1646932) at the University of Melbourne

 
 

 
 

 

 

 

 
 
 
 
 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 7.05 – JUNE 2022

Research Roundup:

June 2022

Welcome Message

Welcome to the June issue of TSANZ Research Round up. First up, I’ve got some questions for you to think about. What do you need to make your funding applications more competitive? Is there a gap in your skills, knowledge base, network, or something else, but you just can’t find a way to fill it? Is there some training that you would really like to get, but can’t find a course or person able to provide it? TSANZ wants to fix these problems for you, but we can’t do that unless you tell us what your needs are.

To do this, please fill out the training needs analysis survey, which should take around 12-minutes and can be accessed here. Big thank you to everyone who has already completed this survey. So that we can provide all our members with the best and most tailored support possible, we need to get at least 300 people to complete this survey, but so far, we have about 100. Thank you to everyone who has already done this. It’s very much appreciated. Would you mind asking anyone and everyone around you to also fill this out? If you like, you could even try and skew the data by having everyone you know request the same training needs, to try and get TSANZ to deliver the support you need first. On that note, Graham, John, Anne, and Hannah, no need to re-read that last sentence or look closer into submissions from my network; Nothing to see here.

While we’re on the topic of training, early bird registration is now open for the inaugural TSANZSRS Education Hub. This is an exciting opportunity for a much needed in-person event, running in Sydney from the 14-15th of October. Yes, you read that right, IN PERSON! There will be a host of workshops to choose from, including sessions to help build skills in crafting successful grant applications and how to get your research published in high quality journals. Of course, one of the biggest benefits of an in-person gathering will be facilitated through the Friday night networking event. Providing an opportunity to reconnect in person with distant colleagues and begin to explore new associations among members with shared interests.

In some other exciting news, a big congratulations to all recipients of Lung Foundation Australia’s Hope Research Fund Grants, and to our members who have been successful with NHMRC Clinical Trials and Cohort Studies Grants. It is fantastic to see this essential respiratory research being supported through competitive grants and awards. Speaking of successes, we would love to help celebrate any of your recent achievements with the broader TSANZ membership by sharing the news in future editions of the research roundup. Instructions on how to do this are provided below.

As usual there are some excellent reads from the Research Review, and Respirology has a special issue focused on occupational lung health. Cure4CF’s Holckner Family CF Impact Grant has just opened, with up to $500,000 is available for Cystic Fibrosis research seeking to develop therapies and cures for the disease. Recruitment is being sought for patients with COPD or ILD for SINFONIA, a singing for breathing trial, and views from healthcare professionals within three different studies. If you have a minute to spare, please help support fellow TSANZ members by contributing to their research.

Finally, some inspirational words to end this edition of research round-up come from anonymous “Not all storms come to disrupt your life, some come to clear your path”.

Happy researching everyone.

A/Prof Kristin Carson-Chahhoud
Chair, Research Sub-Committee 

TSANZ Training Needs Analysis Survey

We are asking all members to complete our first-ever Training Needs Analysis Survey regardless of role, profession, or whether you are clinical or not.

This short survey will only take approximately 12 minutes to complete and is a set of multiple-choice questions.

The Thoracic Society is committed to continuing its development of education offerings and strives to improve our learning opportunities and develop education where gaps exist. We will use this data to evaluate all continuous professional development programs and improve our educational offerings.

This training needs analysis survey utilises the Hennessy-Hicks training needs assessment tool (Hennessy D, Hicks C 2011), endorsed by the World Health Organisation. It will provide reliable information about current performance levels and skill areas requiring further development. It is considered best practice for analysing training needs helping to address problems in turning knowledge into action.

The Thoracic Society would like to thank you for taking the time to complete this survey.

Open Awards

Thoracic Society Awards

TSANZ NZ Branch ASM 2022 Travel Grant – closing 1st August 2022

How to participate

Follow the links above to access each award application and follow the instructions online.

Please email the TSANZ Awards Coordinator (TSANZawards@thoracic.org.au) with any questions, comments or enquires.

Education Hub Logo

TSANZ Education Hub

Registrations are now open for the inaugural TSANZSRS Education Hub on 14-15 October 2022, at Rydges World Square, Sydney.

There will be a wide range of workshops, courses and skills sessions available to choose from, including research skills updates, such as how to craft successful research grant and funding applications, and writing research outcomes for publication.

To view the programme, please visit the Education Hub website.

Of course, there will also be an opportunity to reconnect with colleagues from across Australia and New Zealand at the networking function on the evening of Friday 14th October.

All programme content will be recorded and made available to delegates for 6-months after the Education Hub, giving you access to the entire program, regardless of which sessions you attend at the time.

Register before 4th August 2022 and receive the early bird rate.

We look forward to welcoming you to the TSANZSRS Education Hub in October.

 

Open Request for TSANZ Member Achievements

TSANZ would like to invite members to share their achievements. One of TSANZ Strategic Objectives is to raise the profile of the respiratory research workforce in Australia and New Zealand, especially those who are TSANZ members. As part of this we would like to share member success in our monthly Research Roundup.

Examples of achievements we would like to hear about are:

  • Receipt of major grants, such as grants from the Medical Research Future Fund or the National Health and Medical Research Council
  • Receipt of major honours, such as those from the Order of Australia
  • Notable recent journal publication
  • Completion of a PhD

Please send notification of these achievements to TSANZawards@thoracic.org.au, along with a short blurb (2-3 sentences) about your achievement for us to share. If applicable please include documentation of your achievement, and, if you would like, provide a photo of yourself. Please also share with us success of your fellow TSANZ members!

TSANZ Members awarded the Lung Foundation Australia’s Hope Research Fund 2022 Grant

At the recent Hope Research Fund lunch on 2 June, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer. 

Huge congratulations to our talented TSANZ members, 
Lung Foundation Australia – Ludwig Engel Research Grant: Dr. Hayley Scott
Lung Foundation Australia Andrew Harrison Bronchiectasis Fellowship: Prof. Julie Marchant
Lung Foundation Australia John Farrell COPD Fellowship: Dr. Narelle Cox
Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD: Dr. Arwel Jones
Lung Foundation Australia – Better Breathing Foundation PhD Scholarship in Chronic Lung Disease (full): Mrs. Jessica Walsh
Lung Foundation Australia -Ivan Cash Research Grant: Dr. Sheetal Deshpande
Lung Foundation Australia – Lizotte Family Research Grant: Dr. Peter Bell
PACT Grant-In-Aid: Dr Hayley Barnes and Dr Ryan Hoy
CREATE Hope Fellowship (scientific): Dr Gang Liu
CREATE Hope Fellowship (clinical): Dr Ingrid Cox
LUCAP PhD Topup: Dr Jess Nash

The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer. 

Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded. 

With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research. 

TSANZ Members Success with NHMRC Grant Funding

TSANZ wishes to extend our congratulations to the TSANZ Members who were awarded NHMRC Clinical Trials and Cohort Studies Grants. Over $75.3 million in funding was granted to support 33 clinical trials and cohort studies. It was excellent to see some of this go towards respiratory research. 

Professor Gregory Fox, from the University of Sydney was awarded $4.77 million for The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis. From Professor Fox; “Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada.”

Dr Danielle Wurzel, from the University of Melbourne was awarded $3.72 million for Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years. From Dr Wurzel; “First Nations children have unacceptably high rates of lung disease which means poorer adult health. Our project, co-designed with Aboriginal researchers, scientists and clinicians, will address the disproportionate burden of lung disease in First Nations People. Through a birth cohort study of First Nations People we will evaluate a range of exposures and biomarkers for lung health indicators to identify high-risk children. This research will inform interventions to prevent early-onset chronic lung diseases and will assist clinicians, researchers and policy makers in our shared vision to Close the Gap. Other TSANZ members who are Chief investigators on this project are Prof Shyamali Dharmage (UoM), Prof Anne Chang (QUT), Prof Paul Robinson (UoS), (QIMR) and Dr Gabrielle McCallum (Menzies).”

Associate Professor Adrian Lowe, from the University of Melbourne was awarded $7.56 million of Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT. From Associate Professor Lowe; “Childhood asthma is a major public health problem worldwide, and poor lung function in childhood increases the risk of chronic adult lung disease and early death. There are currently limited strategies to prevent children developing asthma and early lung function deficits. It has been hypothesised that impaired skin barrier in early life can increase risk of allergic sensitisation and asthma.  In this follow-on study of our large NHMRC funded trial, we will test if an intervention to improve skin barrier can reduce early life asthma and lung function deficits.”

External Grant Opportunities

Cure4 Cystic Fibrosis Foundation National Grant Round

Grant Round Now Open – Holckner Family CF Impact Grant

In 2022 Cure4CF will provide up to $500,000 to advance medical innovations in cystic fibrosis. We prioritise research with a clear translational path that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life. Grant round closes August the 5th at 5pm ACST.

Visit https://www.cure4cf.org/research-grants-2022/ to find out more

Merck Investigator Studies Program (MISP): SARS CoV-2/COVID-19 Investigator Initiated Grants

Effective January 2022, the Merck Investigator Studies Program Review Committee (MISP-RC) for SARS CoV-2/COVID-19 TREATMENT will accept FUNDING ONLY, PRECLINICAL, and CLINICAL, NON-INTERVENTIONAL, submissions within our current areas of interest (AOI). This is a competitive review process that will be conducted by the MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below. Clinical, interventional/treatment AOIs will be added at an upcoming date; until then any submission for use of molnupiravir in a treatment or prophylaxis study WILL NOT be reviewed. The following areas are of interest to Investigator Studies Program Committee:

  • In vitro studies to assess the antiviral activity of NHC against RNA viruses of human significance
  • Proof of concept studies demonstrating the antiviral activity and mechanism of action of molnupiravir in validated animal models of zoonotic RNA viral infections
  • In vitro or animal studies to assess the development and mechanism of viral resistance to NHC/molnupiravir by RNA viruses of human significance
  • In vitro or animal studies to assess the relationship between the number and type of accumulated errors in the viral genome and impact on viral infectivity
  • Studies that may validate a standardized definition for post-acute SARS-COV2 (PASC) or long-COVID
  • Studies that may provide clinical or biomarker predictors of infection severity in COVID-19 in children (<18 yr olds)
  • Studies that may better characterize moderate/severe breakthrough infections and/or provide predictors of severe COVID-19 in high risk vaccinated populations such as the elderly, transplant recipients (solid organ or allogeneic stem cell transplant) and other immunocompromised/immunosuppressed patient populations, persons with BMI >30, DM, cardiopulmonary disease, and/or BIPOC, LatinX, native peoples.

Please complete the corresponding preclinical or clinical PROTOCOL and BUDGET templates via the Company’s on-line study management system (in US) or your MSD country representative (outside US). The submissions will be collectively reviewed and selected by the MISP Committee.

https://engagezone.msd.com/SARS_Cov-2_COVID-19.php

Review Cycle 2: May 26, 2022

Review Cycle 3: August 24, 2022

If you would like more information, or are interested in submitting a proposal related to an area of interest please email mandeep.sembi@msd.com

Surveys and Research

SINFONIA Singing for breathing trial

SINFONIA is a multi-site, online singing for breathing trial for people with COPD or ILD and their caregivers. This study is led by a research team at Monash University (A/Prof Natasha Smallwood) and aims to investigate if group singing classes assist with improvement in symptom management and overall wellbeing. The trial is not just limited to people in Victoria, as people from around Australia can be referred or self-refer to take part. In case you are interested in telling your patients about the study, the eligibility criteria are:

  • Patients aged over 18 with a confirmed diagnosis of COPD or ILD on lung function (within last 2 years) or CT (last 5 years)
  • Stable on treatment for at least 4 weeks (i.e. no new or changed cardiorespiratory medications or hospital admissions for COPD or ILD)
  • Breathless: mMRC ≥ 2
  • NOT currently participating in pulmonary rehabilitation
  • Capable and willing to give informed consent
  • Carers aged over 18 years may also participate

Participants in the online singing group will attend a 90-minute online group singing session once a week, for 12 weeks. People randomised to the control group (delayed entry) will be offered to join the singing sessions after 3 months.

Patients or clinicians can refer by contacting our team’s research assistant Catherine Buchan: c.buchan@alfred.org.au.

Physiotherapy and exercise management of patients undergoing thoracic surgery across the continuum

This research project is aiming to describe the current practices of exercise health professionals (e.g., physiotherapy, exercise physiology, allied health assistants) when assessing and managing patients undergoing thoracic surgery for lung cancer across all phases of the treatment continuum (pre-operative to 12 months post-operative).  

You are invited to participate in this project if you are a registered exercise health professional working with people with lung cancer undergoing thoracic surgery across the continuum of care, including pre-operative, post-operative acute, and community/outpatient programs (e.g., pulmonary rehabilitation and/or oncology rehabilitation).  On completion of this survey, you will be given the opportunity to enter the draw to win a new Apple iPad. 

The survey will close on July 22nd.

To complete the survey and to read the Plain Language Statement please visit https://bit.ly/thoracicsurgsurvey.

For further information, please contact A/Professor Catherine Granger Catherine.Granger@unimelb.edu.au or Georgina Whish-Wilson gwhishwilson@student.unimelb.edu.au.

Views of healthcare professionals on smoking cessation options project

Are you a health professional who provides smoking cessation advice to the people you see?

Researchers at The University of Queensland are seeking health practitioners for research exploring smoking cessation treatment in a changing regulatory environment. Participation involves a 30 minute interview about your experiences and views on smoking cessation options.

This project is led by Dr Kylie Morphett at the UQ School of Public Health and you can find out more and register your interest here: https://tobacco-endgame.centre.uq.edu.au/our-research/views-healthcare-professionals-smoking-cessation-options-project

We need healthcare professionals involved in pulmonary rehabilitation to complete our online survey

Researchers from the University of Newcastle are conducting an online survey study to better understand current pulmonary rehabilitation programme practices for prescribing exercise intensity for people with chronic obstructive pulmonary disease (COPD). We want to know:
1) How exercise intensity is commonly prescribed; and
2) How the availability of different resources influences current practices around prescription of exercise intensity.

You are eligible to complete the online survey if you have knowledge of how the exercise training is prescribed for people with COPD who attend the pulmonary rehabilitation programme where you work. If this is not your area of expertise, you may forward this study information on to a healthcare provider who would be best placed to complete the survey on behalf of your pulmonary rehabilitation programme.

Participation in this study involves completing a one-off online survey. It is estimated that this survey will take 20-30 minutes to complete. You do not need to complete the survey in one session. You can save it and come back to it later. We will not ask you to enter any information that identifies you or the pulmonary rehabilitation programme where you work.
You can find more information about the survey, and complete the survey, by clicking on this link: https://redcap.hmri.org.au/surveys/?s=989TJJH4NETCY7LY

We are also conducting a parallel survey of people with COPD. If you could please help to distribute this to people who are living with COPD and attend, or have attended, your pulmonary rehabilitation programme, that would be much appreciated. The study information and flyer (with the COPD survey link) that can be sent to people with COPD, can be found by clicking this link: COPD survey (https://1drv.ms/u/s!Ar_gKTMrKI41gWHGMFe57HUfd8p_?e=KBKyxg)
Please contact the lead researcher, Dr Hayley Lewthwaite (hayley.lewthwaite@newcastle.edu.au), if you have any questions about
the online surveys.

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

tb pod logo

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 5.04 – JUNE 2020

VOLUME 5.03 – APRIL 2020

Research Roundup:

April 2020

.

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. We currently have two invitations on offer – one for a study in Identifying barriers and facilitators to the implementation of best practice for pulmonary fibrosis in Australia, the other for participation in the ASCOT trial.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. You will be featured in an upcoming Research Roundup and also published on the limbic website. This is a great opportunity to tell us about your research and inspiration, and provides a platform to be able to connect your passion project with our network of TSANZ members and the limbic subscribers. Details can be found here.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Respirology – Editor’s Choice 

Respirology Issue 25.4 April 2020

 

We won’t find what we don’t look for: Identifying barriers and enablers of chronic wet cough in Aboriginal children

Pamela Laird, Roz Walker, Mary Lane, Anne B. Chang and Andre Schultz

 

DOI: 10.1111/resp.13642

 

Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible?

Maria P. Arellano-Maric, Christine Hamm, Marieke L. Duiverman, Sarah Schwarz, Jens Callegari, Jan H. Storre, Claudia Schmoor, Marc Spielsmanns, Wolfgang Galetke and Wolfram Windisch

 

Principal investigator Maria Paola Arellano-Maric, MD (left) and senior investigator Prof. Dr. Wolfram Windisch (right)

DOI: 10.1111/resp.13704

ASCOT Trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

Invitation

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland

Professor of Physiotherapy, Monash University and Alfred Health

Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University

Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 5.04 – JUNE 2020

VOLUME 5.02 – MARCH 2020

Research Roundup:

March 2020

.

Welcome Message

By now I’m sure you’ve heard that TSANZSRS 2020 has been postponed until 29 April – 4 May 2021. The TSANZ Board released a letter and FAQ outlining this decision on 12 March 2020.

The Board is busy working through all the issues that have arisen from this decision and we will be in touch with updates as they happen. Whilst the the Research Sub-Committee has finalised most awards, we are now looking at how to publicly acknowledge 2020 award recipients. 

COVID-19

Infectious diseases research is a significant area of strength in Australia and the TSANZ acknowledges the important work of our Australian researchers who are international leaders in research surrounding COVID-19. Examples include the creation of the vaccine candidate for COVID-19 by the University of Queensland – achieved in just three weeks! Scientists at CSIRO’s state-of-the-art biologics production facility in Melbourne have already begun small-scale testing. Doherty Institute researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection (published in Nature) while CSIRO’s research aims to get a better understanding of the virus – how long it takes to develop and replicate, how it impacts the respiratory system and how it can be transmitted. 

We also acknowledge the support of the Australian Government that will invest $30 million for COVID-19 research to enable Australian researchers to contribute to global efforts to control the outbreak. In addition, NHMRC recognises that the COVID-19 pandemic may be affecting the research of current grant holders. If you have received a grant and circumstances have changed – for example, there has been a delay in your Research Activity because of involvement in the clinical or public health response – you can apply to vary your grant. Variations that may be relevant due to the impact of COVID-19 include: Deferral of commencement date and requests for grants applications, deferral of an in-progress grant and extended leave requests, extended end date, change to a research plan or change to chief investigators. For more information please visit: https://www.nhmrc.gov.au/funding/manage-your-funding/vary-your-grant.

TSANZ are collaborating to support the Australian Living Evidence Consortium who, with Cochrane Australia are working to develop a National COVID-19 Clinical Evidence Taskforce. There is a survey below which will help to determine high-priority clinical questions and a request for EOIs to join the guideline panel. I encourage all interested parties to contribute to this work through the article below.

We wish you all the best in your work and in preparation of your grant applications.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

National COVID-19 Clinical Evidence Taskforce

Dear colleague,

The Australian Living Evidence Consortium and Cochrane Australia are working with others to support the development of a National COVID-19 Clinical Evidence Taskforce. As part of this we are working with peak professional bodies to develop living, evidence-informed guidance for primary, hospital and critical care of adults and children with suspected or confirmed COVID-19 infection. Guidance will be updated weekly as new evidence emerges.

We would like your suggestions for high-priority clinical questions to be addressed by this guidance.

Please suggest questions by completing the form at https://forms.gle/SDS9t2tMhiHvnRoPA by 9pm Sunday March 22.

We are also seeking interested clinicians to join guideline panels. These will initially be convened next week, and then meet regularly over the next weeks and months to review emerging evidence and refine the recommendations. To express your interest in membership in a guideline panel, please email your CV to Dr Britta Tendal, Senior Research Fellow at Cochrane Australia at britta.tendal@monash.edu by 9pm Sunday March 22. 

If you have any queries please contact Dr Tari Turner, Senior Research Fellow at Cochrane Australia at tari.turner@monash.edu

Thank you

Respirology – Editor’s Choice 

Respirology Issue 25.3 March 2020

 

Global Lung Function Initiative‐2012 ‘other/mixed’ spirometry reference equation provides the best overall fit for Australian Aboriginal and/or Torres Strait Islander children and young adults

Tamara L. Blake, Anne B. Chang, Mark D. Chatfield, Julie M. Marchant and Margaret S. McElrea

 

DOI: 10.1111/resp.13649

Study participant from Thursday Island performing spirometry (with permission by the Queensland Government)

 

Association of serious adverse events with Cheyne–Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis

Faizan Javed, Renaud Tamisier, Jean-Louis Pepin, Martin R. Cowie, Karl Wegscheider, Christiane Angermann, Marie-Pia D’ortho, Erland Erdmann, Anita K. Simonds, Virend K. Somers, Helmut Teschler, Patrick Levy, Jeff Armitstead and Holger Woehrle

 

 Schematic representation of CheyneStokes respiration signal.

DOI: 10.1111/resp.13613

Invitation

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland

Professor of Physiotherapy, Monash University and Alfred Health

Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University

Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 5.04 – JUNE 2020

VOLUME 3.08 NOVEMBER 2018

Research Roundup:

November 2018

.
 

Welcome Message

We are now well into the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Subcommittee is in full swing reviewing award applications, the SIG convenors are busy reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2019 we are expecting another large conference, having received approximately 400 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2019.

Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

Finally, here is an open invitation for TSANZ members who would like to share their Research Story with us. We have been working with The limbic for nearly three years now to bring you the latest research media in our research roundup. Part of this roundup occasionally features TSANZ members and their “holy grail”. This section will also feature on the limbic’s respiratory news website and be visible to other subscribers. If you would like to share your holy grail, please tell us a little bit about yourself here.

Enjoy the November edition of your research roundup and please check out the surveys below!

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

Research and Career Development Awards

Maurice Blackburn ASM Travel Award extended –  closes 3 Dec 18

Boehringer Ingelheim COPD Research Award – closes 3 Dec 18

TSANZ Indigenous Respiratory Nursing Award – reopened – closes 3 Dec 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency extended –  closes 3 Dec 18

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

TSANZ Webinar Series

“What’s in a cough? Implications for the care of people with flu and MROs” with Professor Scott Bell

Event Date: Tuesday, 27th November 2018

Time: 2pm – 3pm AEDT

Duration: 45 minutes

The CF-Air Research Program has provided novel data regarding the prevalence of shared strain infection in CF, potential acquisition pathways including from the natural environment and via direct person-to-person spread of bacteria. This was possible due to the establishment of a multi-disciplinary research team to support studies of the mechanism of cross-infection using CF as a model. Our current work focusses on other CF pathogens and origins and acquisition pathways including Mycobacterium and the potential spread of infection amongst patients with non-CF lung diseases. We have evaluated cough aerosols are highly innovative as no such equipment has been replicated to date, providing in vivo cough studies, safely delivered to patients with respiratory infections.

Only limited places available! Don’t miss out!

The presenter: Professor Scott Bell

Professor Scott Bell is Executive Director – Research, MNHHS and a Senior Physician of the Adult Cystic Fibrosis Centre at TPCH (>320 patients) where he has worked since 1996. He is currently the Editor-in-Chief of the Journal of Cystic Fibrosis. He leads the Lung Bacteria Laboratory at QIMR Berghofer Medical Research Institute in Brisbane. Scott has over 200 peer reviewed publications and has received grant support in excess of $12 million over the past 10 years. His research interests include the CF microbiology, acquisition pathways for human infection and has a long history of supporting multi-disciplinary research. He has been PI on numerous pivotal CFTR modulator trials and is global PI on a novel approach to combination therapies for CFTR correction.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

Respirology – Editor’s Choice

Respirology Issue 23.11 (November 2018)

Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD

Floor J. Hartjes, Judith M. Vonk, Alen Faiz, Pieter S. Hiemstra, Thérèse S. Lapperre, Huib A.M. Kerstjens, Dirkje S. Postma, Maarten van den Berge and the Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group

DOI: 10.1111/resp.13312

 

               Groningen Research Institute for Asthma and COPD (GRIAC), The Netherlands.

Multidimensional improvement in connective tissue disease associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus

Yasuhiko Yamano, Hiroyuki Taniguchi, Yasuhiro Kondoh, Masahiko Ando, Kensuke Kataoka, ​​​​​​​Taiki Furukawa, Takeshi Johkoh, Junya Fukuoka, Koji Sakamoto, Yoshinori Hasegawa

DOI: 10.1111/resp.13365

 

Research team at Department of Respiratory Medicine and Allergy at Tosei General Hospital in Seto, Japan.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma to reach concensus. This is the second round of a multi-national Delphi process to reach a consensus and there may be follow-up questions based on the answers we receive from this round (with likely 2-3 rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Masters by Research by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=78M2nn61

*for issues with the survey link, please try copying and pasting into your browser and/or using Firefox browser. Feel free to contact the investigators with any questions*

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai
 JamesMichael.Ramsahai@uon.edu.au

 

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.07 OCTOBER 2018

Research Roundup:

October 2018

.
 

Welcome Message

Welcome to October – a busy month for awards as the first wave of awards close and the second wave of awards open. We are pleased to announce that the Boehringer Ingelheim COPD Research Award is now open, and the Boehringer Ingelheim Australia COPD Travel Award and Boehringer Ingelheim New Zealand COPD Travel Award have been added to the TSANZSRS2019 abstract submission portal.

Don’t forget that Abstract-linked awards are closing soon! (this Friday!) Apply now for some of the many abstract-linked awards and, for early career researchers, take the opportunity to present your work to our full membership by entering the Ann Woolcock New Investigator competition.

The full list of awards can be found in the Open Awards section in this newsletter and on the TSANZ Awards web page.

Lastly, please support the research of TSANZ members and supporters by contributing to the surveys at the end of this newsletter.

Enjoy the October edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

Abstract-linked awards

To apply for an abstract-linked award, you must complete the application coversheet using the upload functionality in the online abstract submission portal

Ann Woolcock New Investigator Award

Boehringer Ingelheim COPD Travel Award (AU)

Boehringer Ingelheim COPD Travel Award (NZ)

Janet Elder International Travel Award

Japanese Respiratory Society (JRS) Early Career Development

TSANZ Travel Grants to 2019 ASM

For more information visit http://www.tsanzsrs2019.com/abstracts/tsanz-awards-criteria/

Abstracts close 12 October 2018 6pm AEST

Research and Career Development Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease – closes 18 Nov 18

Maurice Blackburn ASM Travel Award – closes 18 Nov 18

Boehringer Ingelheim COPD Research Award – closes 3 Dec 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Cystic Fibrosis Australia Awards

Cystic Fibrosis Innovation Grant – closes 28 Jan 2019

Lung Foundation Australia Awards

The Lung Foundation Australia David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019 – closes 10 Oct 18

Lung Foundation Australia/ Cochrane Airways Australia Scholarship 2019 – closes 2 Nov 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Cystic Fibrosis Innovation Grant

Cystic Fibrosis Australia (CFA) is pleased to announce the 2019 Innovation Grant for post-doctoral researchers, currently working in cystic fibrosis (CF) research. This grant is awarded annually to one applicant for one year.

The Innovation Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage.  Innovative applications relating to any aspect in the field of CF are encouraged, even those lacking pilot data.  The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.

The Innovation grant will be offered to post-doctoral researchers currently working in or proposing to work in CF research.  The researcher will have completed a research higher degree in CF or a related area within the last ten years.

The recipient of the Innovation Grant is required to provide progress reports on their research to CFA every six months.  In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.

The maximum amount awarded under the Innovation Grant will be $80,000.  The actual amount provided will be subject to approval of the applicant’s budget.

Applications can be made through the website of The Thoracic Society of Australia & New Zealand (TSANZ) and must be received by TSANZ by late January 2019.

Apply Here

TSANZ Webinar Series

Thursday 11th October 2018, 1pm AEDT | 3pm NZDT

Research Techniques to Study Respiratory Diseases – Prof Phil Hansbro

The webinar will be discussing a range of techniques that are valuable for studying disease, identifying new therapeutic targets and testing novel treatments. 

Professor Phil Hansbro Biography:

Professor Hansbro is a group leader and holds a personal chair in immunology and microbiology at the Hunter Medical Research Institute and University of Newcastle, Australia and is Associate Director of the Priority Research Centre for Asthma and Respiratory Diseases there. He is also an NHMRC Principal Research Fellow. He has established internationally recognised research programs in infections, COPD, asthma and recently lung cancer. His group has developed several novel mouse models of the important diseases (COPD, severe, steroid-insensitive asthma, early life infection & lung cancer). He has interrogated them (immune, histological, pathological, lung function & molecular analysis) to substantially further our understanding of pathogenesis and to develop novel therapies. He performs complimentary collaborative clinical and multi-disciplinary studies and collaborates widely. He publishes extensively in influential journals and he is regularly invited to present internationally including as plenary and to chair sessions. He has a substantial funding record of obtaining nationally competitive grants that support his group. He undertakes substantial mentoring and supervision activities of junior researchers, regularly sits on grant review panels and is on the editorial board of 4 journals. He is an active advocate for respiratory research in lobby groups and is regularly in the press promoting research and funding.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars with Professor Allan Glanville and Sally Powell are now available for on-demand viewing. For more information, please CLICK HERE!

Thoracic Society Medals and FThorSoc

Each year the TSANZ invites members to nominate their peers to be considered for a number of prestigious awards, namely: Research Medal, Society Medal and 50th Anniversary Medal for Education & Training. Nominations for these awards are now invited from members of all backgrounds and professions. Recipients of these awards will be presented with their medals at the TSANZSRS 2019 Gala Dinner and Awards Evening.  

Members are also encouraged to consider applying to become a Fellow of TSANZ. Applications for Fellow status are reviewed by the Professional Standards Subcommittee and reviewed and endorsed by the Board. Fellow status is available to members from all professions who demonstrate an exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ. Recipients of the post nominal FThorSoc will be announced at the AGM 2019.

The Research Medal, Society Medal, 50th Anniversary Medal and Fellows of TSANZ are distinctive awards – a testament of the recipients’ exceptional contributions in the field of respiratory health in Australia or New Zealand.

Read below for more details & how to apply/nominate your peers. Closing date: Friday 2nd November 2018

TSANZ Fellowship 

DOWNLOAD APPLICATION FORM

For more information please visit: https://www.thoracic.org.au/about-us/fellow-of-thoracic-society-australia-new-zealand

Background:

The TSANZ Board makes an annual call for nominations for members to be awarded Fellow status. The call is made to members from all professions who demonstrate exceptional contribution to the field of respiratory health in Australia or New Zealand. If the Fellow status is approved, the member will be able to use the post nominal FThorSoc and will be able to continue to do so whilst a financial member of TSANZ.

The main aims of the Fellow status are:

  1. To recognise expertise and experience in respiratory medicine and/or research and/or respiratory health service provision.
  2. To acknowledge a major contribution and commitment to advancing respiratory health in Australia and/ or New Zealand.

Requirements for Awarding of FThorSoc:

TSANZ members may apply to become a Fellow of the Thoracic Society of Australia and New Zealand (FThorSoc) if they demonstrate exceptional contribution to 5 of the 7 criteria listed below. For the remaining 2 criteria, the applicant must demonstrate a proven track record.

The criteria are:

  1. A continuous financial member of TSANZ for five consecutive years in Australia and/or New Zealand as well as a minimum of ten years post-specialist qualification
  2. Contribution to advocacy and/or policy development
  3. Service within the community
  4. Distinguished leadership
  5. Contribution to research
  6. Contribution to teaching or training
  7. International recognition in his or her discipline

List of Fellows of The Thoracic Society Australia and New Zealand:

The following individuals have been nominated by their peers, recommended to the Board by the Professional Standards Sub-Committee and formally recognised by the Board for their exceptional contributions to respiratory health in Australia and New Zealand.

FTHORSOC 2013

FTHORSOC 2014

FTHORSOC 2015

FTHORSOC 2016

FTHORSOC 2017 

FTHORSOC 2018 

___________________________________________________________

Awards By Nomination

The Research Medal, Society Medal and 50th Anniversary Medal are awards for distinguished service. Nominations for each of these awards are invited as outlined below. 

 

The Research Medal 

About 

The Research Medal may be awarded each year in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research.

HOW TO NOMINATE

Candidates

The Research Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved Research Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate.  

The Society Medal 

About

The Society Medal was conceived as an acknowledgement of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy. The inaugural Society Medal was presented at the annual dinner in Canberra in 1992 to Dr Maurice Joseph, who ably embodied the qualities envisaged by this senior prestigious award.

HOW TO NOMINATE

Candidates

The Society Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved Society Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate.  

The 50th Anniversary Medal for Education and Training 

About

The 50th Anniversary Medal is an award introduced in 2011 to mark the Society’s 50th Anniversary. The 50th Anniversary Medal may be awarded each year in recognition of outstanding contributions to respiratory education and training in New Zealand or Australia. The award recognises an individual who has demonstrated sustained excellence in education and training. This might take the form of formal and informal teaching within a university, hospital or other health care setting; curriculum development at an undergraduate or postgraduate level; using research to enhance the efficacy of educational activities; career mentoring of junior members of the Society; integration of teaching into clinical practice; or advocacy on behalf of medical education as applied to respiratory medicine.

HOW TO NOMINATE

Candidates

The 50th Anniversary Medal is open to all financial members of TSANZ including Associate members. Candidates for this medal are put forward by nomination only.

Recipient

The successful candidate will be presented with an engraved 50th Anniversary Medal at the TSANZ Annual Scientific Meeting. An official notification letter from the President of TSANZ will be sent to the successful candidate. 

Clinical Trials Workshop

The Centre of Excellence is pleased to be hosting a Clinical Trials Workshop on 24 October 2018 from 1 – 4PM at the Hunter Medical Research Institute, Caves Theatre. We believe this session will be of broad interest and would appreciate your support in distributing this invitation as broadly as possible.

We are pleased to confirm 4 experts in the field presenting on:

1:00 – 1:40: Clinical Trials Funding (Prof. Bruce Neal, The George Institute)

1:40 – 2:50: Integrating Public Involvement in Research and Clinical Trials (Prof. William Tarnow-Mordi, NHMRC CTC & Melinda Cruz, Miracle Babies Foundation)

3:20 – 4:00: Designing Implementation Trials (Prof. John Wiggers, University of Newcastle)

An event flyer can be downloaded at: https://www.severeasthma.org.au/wp-content/uploads/2018/09/24Oct2018-Clinical-Trials-Workshop.pdf

Lunch will be served before the event and refreshments during an intermission. Please RSVP your interest for catering purposes to severeasthma@newcastle.edu.au

Respirology – Editor’s Choice

Respirology Issue 23.10 (October 2018)

Annual Southeast Asia haze increases respiratory admissions: A 2-year large single institution experience.

Chew R. Ming, Andrea Ban Yu‐Lin, Mohammad F. Abdul Hamid, Mohd T. Latif, Nurashikin Mohammad, Tidi Hassan

DOI: 10.1111/resp.13325

 

Satellite image of the 2015 SE-Asia haze

 

GeneXpert MTB/RIF for rapid diagnosis and rifampin resistance detection of endobronchial tuberculosis

Qin Zhang, Qing Zhang, Bing‐qi Sun, Chang Liu, An‐na Su, Xiao‐han Wang, Na Liu, Juan Zhang, Jian Kang, Gang Hou

DOI: 10.1111/resp.13316

 

The research team from Shenyang, China, with the GeneXpert MTB/RIF system. From left to right: Xiao-han Wang, Chang Liu, Qin Zhang, Bing-qi Sun (front row); Qing Zhang, Gang Hou, An-na Su, Na Liu (Back row).

Research Project and Survey Requests

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.06 SEPTEMBER 2018

Research Roundup:

September 2018

.
 

Welcome Message

Like many of our members, we have recently returned from the European Respiratory Society Congress where an overwhelming amount of scientific and clinical advances, discussions and debates were had over five days. The abstracts for most sessions can be found here and the limbic have provided us with some articles below highlighting key messages.

Our members had a very successful meeting and we applaud the work by the numerous TSANZ members who were recognised by the ERS for their research, including;

  • Peter Gibson – ERS Gold Medal in Asthma
  • Jodie Simpson – ERS Romain Pauwels Research Award
  • Gary Anderson – ERS Presidential Award
  • Sally Yunsun Kim – Co-funded Long-Term Research Fellowship 2018.
  • Pawan Sharma – Short-term Research Fellowship – April 2018 round
  • Louisa Organ – ERS Fellowship Recipient 2017-2019
  • Louisa Owens – ERS Grant for Best Abstract in Paediatric Respiratory Physiology
  • David Currow – ERS Grant for Best Abstract in Rehabilitation and Chronic Care
  • Deborah Reynolds-Sandford – ERS/ELS Travel Grant for Best Abstract in Patient-Centred Research

Looking ahead, abstracts to the TSANZSRS19 are closing soon, on the 12th of October. This ASM is themed Respiratory Infection and you will begin to see some exciting plenaries, workshops and symposiums online as the program is populated.

We are pleased to announce that the Maurice Blackburn Grant-in-Aid for Occupational Lung Disease and the Maurice Blackburn ASM Travel Award for allied health and nursing are now open. We would also like to remind you that two LFA awards are still open for submissions, including the LFA Cochrane Airways Australia Scholarship 2019 and the LFA David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019

The full list of awards and more information on these can be found in the Open Awards section of this newsletter and on the TSANZ Awards Submissions Portal.

Enjoy the September edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease – closes 18 Nov 18

Maurice Blackburn ASM Travel Award – closes 18 Nov 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Lung Foundation Australia Awards

The Lung Foundation Australia David Wilson PhD Scholarship in Idiopathic Pulmonary Fibrosis 2019 – closes 10 Oct 18

Lung Foundation Australia/ Cochrane Airways Australia Scholarship 2019 – closes 2 Nov 18

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

The Next TSANZ Webinar!

Thursday 11th October 2018

1pm AEDT | 2pm NZDT

Research Techniques to Study Respiratory Diseases – Prof Phil Hansbro

The webinar will be discussing a range of techniques that are valuable for studying disease, identifying new therapeutic targets and testing novel treatments. 

Professor Phil Hansbro Biography:

Professor Hansbro is a group leader and holds a personal chair in immunology and microbiology at the Hunter Medical Research Institute and University of Newcastle, Australia and is Associate Director of the Priority Research Centre for Asthma and Respiratory Diseases there. He is also an NHMRC Principal Research Fellow. He has established internationally recognised research programs in infections, COPD, asthma and recently lung cancer. His group has developed several novel mouse models of the important diseases (COPD, severe, steroid-insensitive asthma, early life infection & lung cancer). He has interrogated them (immune, histological, pathological, lung function & molecular analysis) to substantially further our understanding of pathogenesis and to develop novel therapies. He performs complimentary collaborative clinical and multi-disciplinary studies and collaborates widely. He publishes extensively in influential journals and he is regularly invited to present internationally including as plenary and to chair sessions. He has a substantial funding record of obtaining nationally competitive grants that support his group. He undertakes substantial mentoring and supervision activities of junior researchers, regularly sits on grant review panels and is on the editorial board of 4 journals. He is an active advocate for respiratory research in lobby groups and is regularly in the press promoting research and funding.

CLICK HERE to register! 

________________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars with Professor Allan Glanville and Sally Powell are now available for on-demand viewing. For more information, please CLICK HERE!

________________________________________________________________________________

Respirology – Editor’s Choice

Respirology Issue 23.9 (September 2018)

Increased risk of acute coronary syndrome in patients with bronchiectasis: A population-based cohort study

Chin‐Tun Hung, Shu‐Fen Li, Wei‐Sheng Chung

DOI: 10.1111/resp.13298

 

Research team from the Taichung Hospital and Central Taiwan University of Science and Technology in Taiwan. From left to right: Drs Chin-Tun Hung, Shu-Fen Li and Wei-Sheng Chung

 

Cost-effectiveness of endobronchial valve treatment in patients with severe emphysema compared to standard medical care

Jorine E. Hartman, Karin Klooster, Henk Groen, Nick H.T. ten Hacken, Dirk‐Jan Slebos

DOI: 10.1111/resp.13295

 

Endobronchial valve (EBV), with permission from PulmonX

Pulmonary Fibrosis Awareness month

It is Pulmonary Fibrosis Awareness month and Respirology have a number of articles available as a Topic in Focus. The collection includes a TSANZ position statement and these Articles will be freely available in the awareness month of September.

 

 

Research Project and Survey Requests

Implementation of Severe Asthma Management

About the Survey:

On behalf of the NHMRC Centre of Excellence in Severe Asthma (www.severeasthma.org.au), we request your assistance in completing a short survey regarding the implementation of management strategies for severe asthma. We are seeking feedback from multidisciplinary healthcare professionals in Australia.

The survey is available at the following link: https://www.surveymonkey.com/r/SevereAsthmaCRE

The results from this survey will inform expert forum discussions, ongoing research and development of resources to support translation and implementation of new findings into clinical practice. Our goal is to use this information to develop improved standards of care through the NHMRC Centre of Excellence in Severe Asthma.

This survey consists of 15 questions and we anticipate it will take less than 10 minutes to complete.

If respondents can submit their responses by Friday 02 November 2018 it will be greatly appreciated.

Thank you and kind regards,

Profs. Peter Gibson, Vanessa McDonald and John Upham, on behalf of the Centre of Excellence in Severe Asthma

This survey has been approved by the HNELHD HREC under authorisation number AU201809-09. All responses are completely anonymous and will be kept strictly confidential. If you experience any issues or have any questions, please contact: severeasthma@newcastle.edu.au

 

Management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics

Dear TSANZ Member,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice, specifically with regards to the management of complicated parapneumonic effusions and empyemas with the use of intrapleural fibrinolytics. Insights gained will be considered for future presentation and publication. The estimated time to complete the survey is 10 minutes. Partial responses will not be saved if you exit out the survey early. Your participation is voluntary and anonymous. Responses will be kept confidential. Your contribution is greatly appreciated.

The survey can be completed here: https://hms.az1.qualtrics.com/jfe/form/SV_8ddQsXRFwaqAtPD 

If you have any questions about the survey, please contact the study team at: vholden@som.umaryland.edu

We thank you in advance for your participation.

Sincerely,

Van Holden, MD
Mihir Parikh, MD
Alex Chee, MD
Adnan Majid, MD

Division of Thoracic Surgery & Interventional Pulmonology
Beth Israel Deaconess Medical Center
Harvard Medical School

The attached survey has been approved by the Beth Israel Deaconess Institutional Review Board – The IRB Protocol # is 2018P000052.

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 
 

.

VOLUME 5.04 – JUNE 2020

VOLUME 3.05 AUGUST 2018

Research Roundup:

August 2018

.
 

Welcome Message

 

It is a busy time of year for research administration. Last week we were both in Canberra and were very fortunate to meet with Professor Anne Kelso, NHMRC CEO. We had a very useful discussion with Anne on the lack of research funding achieved by respiratory health in comparison to the massive respiratory burden of disease and we discussed ways to improve this situation. Anne highlighted to us that the success rate of respiratory disease grants was 20.8%, which is well above the national average of 16.2% funding success. This means we have an extremely high quality respiratory workforce conducting research, we just don’t have enough grants being submitted. We all need to work to build workforce capacity. TSANZ will continue to advocate for increased respiratory research funds to support research positions as well as continuing to work with sponsors and donors to fund pilot research and pursue fellowship partnerships. At a local and group level we need each other to support and mentor early and mid-career researchers. Furthermore, in the future the NHMRC Ideas Scheme will award innovation and feasible ideas without weighting track record. These will be a great opportunity for our junior investigators.

The NHMRC grant structure is changing next year and grant review panels will not exist as we know them. Grants will be triaged into top grants (auto-fund), borderline grants, and grants not for further consideration. Grants which are borderline will then be reviewed by a few experts to determine their fundability. It is important that respiratory researchers from varied backgrounds continue to make themselves available to review national grants to ensure appropriate expertise is available. It is important that respiratory experts are reviewing respiratory grants as we best understand their potential impact. Please answer the call to participate on research panels. In doing so you ensure respiratory grants are reviewed by well qualified reviewers.

It is heartening to know that respiratory researchers are some of the most successful in the country. Let’s continue to build our respiratory community so that we can receive the support we need to find the cure and breath easy.

To that end we are pleased to announce our first awards are now open!

A suite of project grants are out to support pilot research into paediatric health, indigenous health, and alpha-1 deficiency. We are also grateful to be again hosting awards with the National Asthma Council Australia and Lung Foundation Australia. Please look below in the open awards article for more information.

Awards linked to abstracts opened with submissions to the TSANZSRS19 and these include the Janet Elder International Travel Award, the Ann Woolcock New Investigator, The Japanese Respiratory Society Travel Award, and the ASM Travel Awards. Please submit your abstract, apply for a travel grant (for ECRs) and join us on the Gold Coast in 2019. Furthermore, our ASM is preceded by the Asian Pacific Congress on Bronchology and Interventional Pulmonology and well worth the extended trip to Queensland.

Enjoy the August edition of your research roundup.

Profs Phil Hansbro & Sandra Hodge

Co-Chairs, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Peter Phelan Research Award – closes 31 Oct 18

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 31 Oct 18

TSANZ Indigenous Respiratory Nursing Award – closes 31 Oct 18

Joint Awards

TSANZ / LFA / CSL Behring Research Award for Alpha-1 anti-trypsin deficiency – closes 31 Oct 18

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closes 31 Oct 18

Lung Foundation Australia Awards

Lung Foundation Australia / Ludwig Engel Grant-in-Aid for Physiological Research 2018 – closes 21 Sep 18

Lung Foundation Australia / Ivan Cash Research Grant-in-Aid For Idiopathic Pulmonary Fibrosis Research 2019 – closes 21 Sep 18

Lung Foundation Australia / Lizotte Family Research Award for Interstitial Pulmonary Fibrosis Research 2019 – closes 21 Sep 18

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Calling Australian and New Zealand Alpha 1 Researchers: The Alpha-1 Foundation is pleased to announce its funding opportunities for the 2018-19 grants cycle.

 

You can help bring the cure within reach!

Log onto www.alpha1.org for more information about our research opportunities, application deadlines and application instructions for the 2018-19 grants cycle. These grants are open to Australian and New Zealand researchers and you are strongly urged to apply.

2018-19 In-cycle letters of intent (LOI) are due by September 28, 2018 using the Alpha-1 Foundation’s online LOI form on ProposalCentral:

https://proposalcentral.altum.com/grantopportunities.asp?GMID=135

For Researchers interested in drug development funding, please visit The Alpha-1 Project’s (TAP) website at: http://www.thealpha-1project.com/ 

Please feel free to email with any questions – Email:  edgloria@alpha1.org

 

Respirology – Editor’s Choice

Respirology Issue 23.8 (August 2018)

Bronchiectasis in indigenous and non-indigenous residents of Australia and New Zealand

Sean R. Blackall, Jae B. Hong, Paul King, Conroy Wong, Lloyd Einsiedel, Marc G.W. Rémond, Cindy Woods, Graeme P. Maguire

DOI: 10.1111/resp.13280

 

Spirometry in central Australia – bronchiectasis disproportionately impacts indigenous populations

 

Childhood measles contributes to post-bronchodilator airflow obstruction in middle-aged adults: A cohort study

Jennifer L. Perret, Melanie C. Matheson, Lyle C. Gurrin, David P. Johns, John A. Burgess, Bruce R. Thompson, Adrian J. Lowe, James Markos, Stephen S. Morrison, Christine F. McDonald, Richard Wood‐Baker, Cecilie Svanes, Paul S. Thomas, John L. Hopper, Graham G. Giles, Michael J. Abramson, E. Haydn Walters, Shyamali C. Dharmage

DOI: 10.1111/resp.13297

 

The population-based Tasmanian Longitudinal Health Study (TAHS) cohort provided the data for this study.

 

Research Project and Survey Requests

Community and patients on their experiences with spirometry

The European Lung Foundation, in partnership with the American Thoracic Society and European Respiratory Society Spirometry Task Force, is seeking input from community and patients on their experiences with spirometry.

We would greatly appreciate it if you can promote this survey through your organisational, community and social networks. The survey will be open until the 21st September 2018.

The survey is available in a number of languages and can be accessed directly through the link below or via the ELF news item also below.

If there are any specific questions please contact Courtney Coleman from the ELF.

The survey is available in Dutch, English, French, German, Greek, Italian, Polish, Portuguese, Russian and Spanish. Participants can select their language from the drop down menu at the top right of the survey.

The news item is available in English, French, German, Greek, Italian, Polish, Portuguese, Russian and Spanish by selecting the country flag at the top left of the website

Sent on behalf of the European Lung Foundation, in partnership with the American Thoracic Society and European Respiratory Society Spirometry Task Force.

 

The Global Lung Function Initiative (GLI) Survey

The Global Lung Function Initiative (GLI) has developed all ages, multi-ethnic reference equations for the most commonly used lung function tests and worked with the broader respiratory community to implement these equations.   

 As part of our broader work we are interested in receiving feedback from the community regarding experiences with implementation of the GLI spirometry and GLI TLCO reference equations, as well understanding any barriers and challenges to implementation. We would greatly appreciate you taking the time to complete the survey to help us understand the experiences of your own research group and/or clinical department.  

This short survey should take ~ 5 minutes to complete and will assist in further informing GLI activities and how we approach future implementation. Individuals and their institutions will not be identified. Outcomes of the survey will be made publicly available on the GLI website. 

We are currently working to develop reference equations for lung volumes and if you or your colleagues have lung volume data in healthy individuals please do visit www.lungfunction.org for more information on this latest GLI initiative.  

Survey sent on behalf of the Global Lung Function Initiative Network: 

https://www.surveymonkey.com/r/DB9LYDJ?PleaseSpecify=[PleaseSpecify_value]

 

Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)

ANZ health professionals who care for people with lung cancer are invited to take part in a survey about the clinical importance and management of cough.

Cough in lung cancer – a health professional survey

The survey link is: https://www.surveymonkey.com/r/cough_in_lung_cancer

Survey results will be used to establish the need and direction for development of further pharmacological and non-pharmacological management strategies for cough in lung cancer.

We are interested in the views of health professionals from the full range of disciplines, specialties and settings involved in caring for people with lung cancer, regardless of their level of experience in managing cough.

Participation in the survey is voluntary and anonymous, and will take approximately 10-15 minutes.

This project is being conducted by a team of researchers from the University of Technology Sydney (UTS) in collaboration with colleagues at the Hong Kong Polytechnic University (HKPU).

For more information, please contact Dr Tim Luckett via tim.luckett@uts.edu.au or 02 9514 4861.

 
 
 
 
 
 

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X